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Abstract
A 68-year-old Caucasian man with hepatitis C virus-
related cirrhosis was admitted to our Unit in February 
2010 for a diagnostic evaluation of three centimetric 
hypoechoic focal liver lesions detected by regular sur-
veillance ultrasound. The subsequent computer tomog-
raphy (CT) led to a diagnosis of unifocal hepatocellular 
carcinoma (HCC) in Ⅵ hepatic segment, defined the 
other two nodules in the Ⅵ and Ⅶ segment as sus-
pected metastases, and showed a luminal narrowing 
with marked segmental circumferential thickening of 
the hepatic flexure of the colon. Colonoscopy detected 
an ulcerated, bleeding and stricturing lesion at the 
hepatic flexure, which was subsequently defined as ad-
enocarcinoma with a moderate degree of differentiation 
at histological examination. Finally, ultrasound-guided 
liver biopsy of the three focal liver lesions confirmed 
the diagnosis of HCC for the nodule in the Ⅵ segment, 
and characterized the other two lesions as metastases 
from colorectal cancer. The patient underwent laparo-
tomic right hemicolectomy with removal of thirty-nine 
regional lymph nodes (three of them tested positive for 
metastasis at histological examination), and simulta-
neous laparotomic radio-frequency ablation of both 
nodule of HCC and metastases. The option of adju-
vant chemotherapy was excluded because of the post-
surgical onset of ascites. Abdomen CT and positron 
emission tomography/CT scans performed after 1, 6 
and 12 mo highlighted a complete response to treat-
ments without any radiotracer accumulation. After 18 
mo, the patient died due to progressive liver failure. 
Our experience emphasizes the potential coexistence 
of two different neoplasms in a cirrhotic liver and the 
complexity in the proper diagnosis and management of 
the two tumours.
© 2013 Baishideng Publishing Group Co., Limited. All rights 
reserved.
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Core tip: A 68-year-old man with hepatitis C virus-
related cirrhosis was admitted to our Unit for a diag-
nostic evaluation of three focal liver lesions detected by 
regular surveillance ultrasound. Computer tomography 
scans of abdomen allowed a diagnosis of single nod-
ule hepatocellular carcinoma (HCC) and showed two 
centimetric liver nodules suspected for metastases and 
a luminal narrowing with thickening of the colon. The 
subsequent colonoscopy and ultrasound-guided biopsy 
of the three focal liver lesions confirmed a diagnosis of 
colorectal cancer with liver metastases together with a 
single nodule HCC. Our experience highlights the po-
tential coexistence of two different neoplasms in a cir-
rhotic liver and the complexity in the proper diagnosis 
and management of the two tumours.
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INTRODUCTION
The incidence of  hepatocellular carcinoma (HCC) is 
currently increasing worldwide, being the leading cause 
of  death in patients with cirrhosis[1,2]. Despite intensive 
surveillance programs, considerable recent therapeutic 
advances and the use of  potentially radical treatments, 
prognosis and life expectancy remain poor in this set-
ting[3]. Curative treatments are applicable for early stage 
tumors only, and include resection, liver transplantation 
and percutaneous ablation, whereas transarterial chemo-
embolization and sorafenib are regarded as non-curative 
treatments able to improve survival in intermediate and 
advanced stages, respectively[4]. 
The burden of  colorectal cancer (CRC) is huge, 
since it is the third most common diagnosed cancer in 
men and the second in women and it is the third leading 
cause of  cancer death in the United States[5]. The liver is 
the most frequent metastatic site for patients with CRC: 
up to 50% of  patients develop hepatic metastases dur-
ing the course of  the disease[6]. However, few data can 
be retrieved from the literature about the incidence and 
management of  liver metastases from CRC in patients 
with cirrhosis.
We describe the coexistence of  HCC and liver me-
tastases from CRC in a patient with hepatitis C virus 
(HCV)-related cirrhosis.
CASE REPORT
A 68-year-old Caucasian man with HCV-related cirrhosis 
was admitted to our Unit in February 2010 for a diagnos-
tic evaluation of  three centimetric hypoechoic focal liver 
lesions in Ⅵ and Ⅶ segment, detected by surveillance 
ultrasound. His medical history included type 2 diabetes 
mellitus requiring insulin treatment and chronic obstruc-
tive pulmonary disease diagnosed few years before.
Upon admission the patient was asymptomatic and 
there was no evidence of  hepatic encephalopathy, ascites 
or peripheral edema. Physical examination was unre-
markable, except for hepatosplenomegaly and palmar 
erythema. Laboratory tests showed microcytic anemia 
(haemoglobin 9.1 g/dL, haematocrit 30%, mean cor-
puscular volume 70 fL) and mild hypoalbuminemia (3.2 
g/dL), while all other liver function tests were normal. 
The Child-Pugh score was A6 showing a good residual 
liver function.
Esophagogastroduodenoscopy detected the presence 
of  medium-size (F2) oesophageal varices and portal hy-
pertensive gastropathy without signs of  active bleeding. 
The subsequent dynamic computer tomography (CT) led 
to a diagnosis of  unifocal HCC in Ⅵ hepatic segment 
(Figure 1), defined the other two nodules in Ⅵ and Ⅶ 
segment as suspected metastases (Figure 2), and showed 
a luminal narrowing with marked segmental circum-
ferential thickening of  the hepatic flexure of  the colon 
(Figure 3). Colonoscopy revealed an ulcerated, bleeding 
and stricturing lesion at the hepatic flexure, which was 
defined as adenocarcinoma with a moderate degree of  
differentiation at histological examination. The levels 
of  carcinoembryonic antigen (CEA) and α-fetoprotein 
were 21.5 ng/mL (NV < 5) and 3.2 ng/mL (NV < 5), 
respectively. 
Ultrasound-guided liver biopsy of  the three focal liv-
er lesions confirmed the diagnosis of  HCC (grading G2 
according to Edmondson-Steiner System) for the nodule 
in the Ⅵ segment and characterized the other two le-
sions as metastases from CRC. Finally, CT scans of  the 
chest did not show metastasis. On one hand, considering 
the good performance status (PS 0), the preserved liver 
function (Child-Pugh score A6), and the tumour stage 
(single nodule < 3 cm, absence of  vascular invasion), 
our patient could be allocated in stage A according to 
Barcelona Clinical Liver Cancer staging system; on the 
other hand, tumour stage of  colon cancer was Ⅳa (T3, 
Nx, M1) according to Tumor-Node-Metastasis Classifica-
tion of  Malignant Tumours.
The patient underwent right hemicolectomy with 
removal of  thirty-nine regional lymph nodes (three of  
them tested positive for metastasis at histological exami-
nation), and simultaneous laparotomic radio-frequency 
ablation (RFA) of  either nodule of  HCC and metastasis. 
No operative complications occurred. As a probable 
consequence of  surgery, the patient developed hepatic 
decompensation after about 2 wk, with onset of  mod-
erate degree ascites. Consequently, the option of  adju-
vant chemotherapy was excluded and the patient began 
oral diuretic treatment with furosemide and canrenone 
with complete clinical response. Abdomen CT and 
positron emission tomography/computerized tomog-
raphy (PET/CT) scans performed after 1, 6 and 12 mo 
showed a complete response to treatments according to 
mRECIST[7,8] for HCC, and RECIST 1.1[9] criteria for 
measurable target lesion of  colon cancer, without any ra-
diotracer accumulation. Finally, determinations of  CEA 
were repeatedly negative. 
After 18 mo, the patient died due to hepatic decom-
pensation and progressive liver failure.
DISCUSSION
Multiple primary cancers are quite rare. Their incidence 
ranges from 0.73% to 11.7%[10], even if  it is steadily rising 
as a result of  the continuous improvement of  treatments 
and the consequent increased cancer survival. Coexis-
tence of  multiple primary tumors is defined by Warren 
and Gates Criteria, i.e., demonstrating that (1) each tumor 
is distinct, (2) each tumor is clearly malignant on histolog-
ical examination, and (3) one of  the two tumors is not a 
metastasis of  the other one. In addition, multiple primary 
tumors are classified into synchronous and metachronous 
according to Moertel classification[11] if  they occur within 
or after 6 mo since the diagnosis of  the first tumor, re-
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spectively. 
We described a case of  synchronous HCC and CRC 
with liver metastases. As already mentioned, the pres-
ence of  multiple primary tumors is rare, and even rarer 
the presence of  synchronous neoplasms. In addition to 
the rarity of  the case, the complexity in distinguishing 
the simultaneous presence of  HCC nodules and metas-
tases in a cirrhotic liver must be emphasized. Indeed, 
the baseline probability of  a new focal liver lesion to be 
a HCC in cirrhosis increases according to nodule size, 
ranging from 66% for nodules between 1 and 2 cm, to 
80% for nodules between 2 and 3 cm in size and up to 
95% for nodules larger than 3 cm[12]. Nevertheless, it is 
possible to find metastases from tumors aroused from 
extra-hepatic sites in a cirrhotic liver, although unlikely; 
consequently, an accurate and complete characterization 
of  the focal liver lesions is mandatory in this setting. In 
our case, we reached the diagnosis through dynamic CT 
scans and subsequent histological confirmation.
The presence of  liver cirrhosis, if  the disease is com-
pensated, does not change per se the therapeutic indica-
tions for non-hepatic tumors[13]. In view of  the good 
residual function of  the liver disease, and after screening 
for portal hypertension and fluid retention, our patient 
was surgically treated with laparotomic right colectomy, 
without operative complications.
The standard of  care for patients with colorectal he-
patic metastases (CRHM) is the systemic chemotherapy 
with or without biologic agents. When metastasis are 
confined to liver and there is no vascular invasion or 
regional lymph node involvement, surgical resection is 
the standard of  care. In patients with cirrhosis, as in non 
surgical candidates, loco-regional therapies as RFA may 
be regarded as one of  the best options for both cura-
tive and palliative approaches[6]. In our patient, the single 
nodule of  HCC, as well as the two CRHM, were simul-
taneously treated during the laparotomic session with 
RFA.
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Figure 1  Computer tomography scans of the abdomen performed on admission. A: Arterial phase computer tomography (CT) scan shows small hepatocellular 
carcinoma nodule with mild enhancement (arrow) in right liver lobe; B: Hepatic venous phase; and C: Delayed phase CT scan at same level shows isoattenuation of 
lesion to liver parenchyma.
Figure 2  Computer tomography scans of the abdomen performed on admission. A: Arterial phase computer tomography (CT) scan shows intense heteroge-
neous rim hyperenhancement of two round metastatic lesions in right liver lobe (arrows); B: Hepatic venous phase; and C: Delayed phase and CT scan show persis-
tent rim enhancement around lesions (arrows). Diagnosis was confirmed at biopsy.
Figure 3  Computer tomography scans of the abdomen performed on ad-
mission. Contrast material-enhanced axial computer tomography scan shows 
luminal narrowing and marked segmental circumferential thickening of the he-
patic colon flexure. Adenocarcinoma was confirmed at colonoscopy and biopsy. 
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Finally, adjuvant chemotherapy was excluded be-
cause of  the post-surgical onset of  ascites, whereas CT 
and PET scans performed after six and twelve months 
showed a complete response to treatments.
Our experience highlights the possible coexistence 
of  two different neoplasms in a cirrhotic liver, although 
rare, and the complexity in the proper diagnosis and 
management of  the two tumors. Even if  dynamic CT or 
MR play a key role in the diagnosis of  HCC, the identi-
fication of  synchronous metastasis may be difficult, due 
to the inherent morphological characteristics of  the cir-
rhotic liver and to the high pre-test probability of  a new 
lesion to be a HCC. Therefore, despite the potential risk 
of  tumour seeding in this setting, ranging from 10% to 
19% according to several reports[14], liver biopsy remains 
a critical diagnostic tool recommended in doubtful 
cases and/or when hepatic metastases are suspected, in 
order to confirm the histological origin of  the primary 
neoplasm and to provide the best therapeutic algorithm 
based on the correct diagnosis.
In absence of  recommendations regarding the best 
combined therapeutic approach, it is desirable to carry 
out the best available therapy for each tumor, when 
feasible. In this line, RFA can be regarded as one of  the 
best options for both curative and palliative approaches 
of  CRHM in compensated cirrhosis[6].
COMMENTS
Case characteristics
Upon admission the patient was asymptomatic, and physical examination was 
unremarkable, except for hepatosplenomegaly and palmar erythema.
Clinical diagnosis
The patient presented with microcytic anemia and imaging evidence of three 
hepatic focal lesions on a background of liver cirrhosis.
Differential diagnosis
Differential diagnosis was performed between hepatocellular carcinoma and he-
patic metastases from colorectal cancer, using dynamic computer tomography 
(CT) and histology of the primary lesion and the three hepatic nodules.
Laboratory diagnosis
Laboratory tests showed microcytic anemia (haemoglobin 9.1 g/dL, haematocrit 
30%, mean corpuscular volume 70 fL) and mild hypoalbuminemia (3.2 g/dL); 
all other liver function tests were normal, whereas levels of carcinoembryonic 
antigen and α-fetoprotein were 21.5 ng/mL (NV < 5) and 3.2 ng/mL (NV < 5), 
respectively.
Imaging diagnosis
Dynamic CT showed a unifocal hepatocellular carcinoma in VI hepatic segment 
and other two nodules suspected for metastases, and it pointed out a luminal 
narrowing with marked thickening of the hepatic flexure of the colon. This latter 
was further detected by colonoscopy as an ulcerated, bleeding and stricturing 
lesion at the hepatic flexure.
Pathological diagnosis
Histological examination defined the stricturing lesion of the colon as adenocar-
cinoma with a moderate degree of differentiation, whereas biopsy of the three 
focal liver lesions confirmed a diagnosis of single nodule hepatocellular carci-
noma (HCC) together with two liver metastases from colorectal cancer.
Treatment
The patient underwent laparotomic right hemicolectomy with removal of thirty-
nine regional lymph nodes, and simultaneous laparotomic radio-frequency abla-
tion of both nodule of HCC and metastases.
Related reports
This case report emphasizes the possible coexistence of two different neo-
plasms in a cirrhotic liver, although rare, and the complexity in the proper diag-
nosis and management of the two tumors.
Experiences and lessons
Even if dynamic CT or colorectal cancer play a key role in the diagnosis of 
HCC, the identification of synchronous metastasis may be difficult, due to the 
inherent characteristics of the cirrhotic liver and to the high pre-test probability 
of a new lesion to be a HCC. Therefore, liver biopsy remains a critical diagnos-
tic tool recommended in doubtful cases and it is mandatory when a liver metas-
tasis from another primary tumour is suspected.
Peer review
This manuscript is interesting and presents a careful observation and discus-
sion regarding diagnosis and management of primary HCC and liver metastasis 
from colorectal cancer. 
REFERENCES
1 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. 
Estimates of worldwide burden of cancer in 2008: GLOBO-
CAN 2008. Int J Cancer 2010; 127: 2893-2917 [PMID: 21351269 
DOI: 10.1002/ijc.25516]
2 Sherman M. Hepatocellular carcinoma: epidemiology, 
surveillance, and diagnosis. Semin Liver Dis 2010; 30: 3-16 
[PMID: 20175029 DOI: 10.1055/s-0030-1247128]
3 Cabibbo G, Craxì A. Hepatocellular cancer: optimal strate-
gies for screening and surveillance. Dig Dis 2009; 27: 142-147 
[PMID: 19546552 DOI: 10.1159/000218346]
4 Bruix J, Sherman M. Management of hepatocellular carci-
noma. Hepatology 2005; 42: 1208-1236 [PMID: 16250051]
5 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. 
CA Cancer J Clin 2013; 63: 11-30 [PMID: 23335087 DOI: 
10.3322/caac.21166]
6 Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD, 
Dorfman GS, Eng C, Fong Y, Giusti AF, Lu D, Marsland TA, 
Michelson R, Poston GJ, Schrag D, Seidenfeld J, Benson AB. 
American Society of Clinical Oncology 2009 clinical evidence 
review on radiofrequency ablation of hepatic metastases 
from colorectal cancer. J Clin Oncol 2010; 28: 493-508 [PMID: 
19841322 DOI: 10.1200/JCO.2009.23.4450]
7 Lencioni R, Llovet JM. Modified RECIST (mRECIST) assess-
ment for hepatocellular carcinoma. Semin Liver Dis 2010; 30: 
52-60 [PMID: 20175033 DOI: 10.1055/s-0030-1247132]
8 Maida M, Cabibbo G, Brancatelli G, Genco C, Alessi N, 
Genova C, Romano P, Raineri M, Giarratano A, Midiri M, 
Cammà C. Assessment of treatment response in hepatocel-
lular carcinoma: a review of the literature. Future Oncol 
2013; 9: 845-854 [PMID: 23718305 DOI: 10.2217/fon.13.33]
9 Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sar-
gent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney 
M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe 
D, Verweij J. New response evaluation criteria in solid 
tumours: revised RECIST guideline (version 1.1). Eur J 
Cancer 2009; 45: 228-247 [PMID: 19097774 DOI: 10.1016/
j.ejca.2008.10.026]
10 Ueno M, Muto T, Oya M, Ota H, Azekura K, Yamaguchi T. 
Multiple primary cancer: an experience at the Cancer Insti-
tute Hospital with special reference to colorectal cancer. Int 
J Clin Oncol 2003; 8: 162-167 [PMID: 12851840]
11 Moertel CG. Multiple primary malignant neoplasms: 
historical perspectives. Cancer 1977; 40: 1786-1792 [PMID: 
332330 DOI: 10.1002/1097-0142(197710)40]
12 Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, 
Nolsøe CP, Piscaglia F, Wilson SR, Barr RG, Chammas MC, 
Chaubal NG, Chen MH, Clevert DA, Correas JM, Ding H, 
Forsberg F, Fowlkes JB, Gibson RN, Goldberg BB, Lassau N, 
Leen EL, Mattrey RF, Moriyasu F, Solbiati L, Weskott HP, 
Xu HX. Guidelines and good clinical practice recommenda-
tions for contrast enhanced ultrasound (CEUS) in the liver-
-update 2012: a WFUMB-EFSUMB initiative in cooperation 
with representatives of AFSUMB, AIUM, ASUM, FLAUS 
699 December 27, 2013|Volume 5|Issue 12|WJH|www.wjgnet.com
 COMMENTS
Maida M et al . Hepatocellular carcinoma and liver metastases from colorectal cancer
and ICUS. Ultraschall Med 2013; 34: 11-29 [PMID: 23129518 
DOI: 10.1055/s-0032-1325499]
13 Cabibbo G, Palmeri L, Palmeri S, Craxì A. Should cirrhosis 
change our attitude towards treating non-hepatic cancer? 
Liver Int 2012; 32: 21-27 [PMID: 22098398 DOI: 10.1111/
j.1478-3231.2011.02629.x]
14 Cresswell AB, Welsh FK, Rees M. A diagnostic paradigm 
for resectable liver lesions: to biopsy or not to biopsy? HPB 
(Oxford) 2009; 11: 533-540 [PMID: 20495704 DOI: 10.1111/
j.1477-2574.2009.00081.x]
P- Reviewers: Charatcharoenwitthaya P, Nojiri S, Sugimoto K, 
Verhelst X    S- Editor: Zhai HH    L- Editor: A 
E- Editor: Wu HL
700 December 27, 2013|Volume 5|Issue 12|WJH|www.wjgnet.com
Maida M et al . Hepatocellular carcinoma and liver metastases from colorectal cancer
Published by Baishideng Publishing Group Co., Limited
Flat C, 23/F., Lucky Plaza, 





© 2013 Baishideng Publishing Group Co., Limited. All rights reserved.
